Oskar Hansson
11 – 20 of 614
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Soluble cerebral Aβ protofibrils link Aβ plaque pathology to changes in CSF Aβ42/Aβ40 ratios, neurofilament light and tau in Alzheimer’s disease model mice
2025) In Nature Aging(
- Contribution to journal › Article
-
Mark
Considerations in the clinical use of amyloid PET and CSF biomarkers for Alzheimer's disease
(
- Contribution to journal › Scientific review
-
Mark
Sex Differences in Longitudinal Tau-PET in Preclinical Alzheimer Disease : A Meta-Analysis
2025) In JAMA Neurology(
- Contribution to journal › Article
-
Mark
Associations between structural brain changes and blood neurofilament light chain protein in treatment-resistant schizophrenia
2025) In Australian and New Zealand Journal of Psychiatry(
- Contribution to journal › Article
-
Mark
APOE4 impact on soluble and insoluble tau pathology is mostly influenced by amyloid-beta
2025) In Brain : a journal of neurology(
- Contribution to journal › Article
-
Mark
Balance and gait disorders in de novo Parkinson’s disease : support for early rehabilitation
(
- Contribution to journal › Article
-
Mark
Toward a biological definition of neuronal and glial synucleinopathies
(
- Contribution to journal › Article
-
Mark
Blood Biomarkers to Detect Alzheimer Disease-Reply
(
- Contribution to journal › Letter
-
Mark
Machine learning prediction of tau-PET in Alzheimer's disease using plasma, MRI, and clinical data
(
- Contribution to journal › Article
-
Mark
Plasma Glial Fibrillary Acidic Protein and Neurofilament Light Are Elevated in Bipolar Depression : Evidence for Neuroprogression and Astrogliosis
2025) In Bipolar Disorders(
- Contribution to journal › Article